|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.9 BDT | -1.24% |
|
-1.85% | -26.39% |
Silva Pharmaceuticals Limited reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was BDT 197.65 million compared to BDT 215.85 million a year ago. Net income was BDT 25.76 million compared to BDT 39.11 million a year ago.
Basic earnings per share from continuing operations was BDT 0.19 compared to BDT 0.29 a year ago. Diluted earnings per share from continuing operations was BDT 0.18 compared to BDT 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.39% | 18.45M | |
| +51.63% | 796B | |
| +40.91% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.32% | 244B | |
| +3.84% | 228B | |
| +12.60% | 214B | |
| +6.99% | 165B |
SILVA PHARMACEUTICALS LIMITED 
